Chemical composition and potential antioxidant, anti-inflammatory, and analgesic efficacy of Cistus albidus L
© 2024 Aziz Zouhri et al., published by Sciendo..
This study aims to assess the chemical composition of the aqueous extract of Cistus albidus L. leaves, as well as the potential of aqueous and hydroethanol extracts of the leaves and seeds as analgesic, anti--inflammatory, and antioxidant agents. The contents of phenolics and inorganic constituents were determined in C. albidus seeds and leaves; antioxidant capacity was assessed by 3 complementary and diverse tests. The carrageenan-induced paw edema technique was used to investigate the anti-inflammatory effect in vivo, and albumin denaturation to evaluate the anti-inflammatory effect in vitro. The acetic acid-induced contortion test, the tail-flick test, and the plantar test were used to assess the analgesic effi cacy in vivo. Chemical analysis was performed by UPLC-MS/MS to quantify several phenolic compounds including catechin (1,627.6 mg kg-1), quercitrin (1,235.8 mg kg-1) and gallic acid (628. 2 mg kg-1). The ICP analysis revealed that potassium and calcium were the main inorganic components in the seeds and leaves of C. albidus. The hydroethanolic extract of the leaves showed the highest content of polyphenols/flavonoids, whereas the highest value of proantho cyanidins was detected in the aqueous extract of the seeds. All extracts showed potent antioxidant activity related to different phenolic compounds (quercetin, gallic acid, astragalin, catechin, and rutin). The aqueous extract of the leaves strongly inhibited paw edema (76.1 %) after 6 h of treatment and showed maximal inhibition of protein denaturation (191.0 µg mL-1 for 50 % inhibition) and analgesic activity in different nociceptive models. The presented data reveal that C. albidus extracts potentially show antioxidant, anti-inflammatory, and analgesic activities that could confirm the traditional use of this plant.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
Acta pharmaceutica (Zagreb, Croatia) - 74(2024), 1 vom: 01. März, Seite 81-99 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zouhri, Aziz [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 01.04.2024 Date Revised 01.04.2024 published: Electronic-Print Citation Status MEDLINE |
|---|
| doi: |
10.2478/acph-2024-0002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370439120 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370439120 | ||
| 003 | DE-627 | ||
| 005 | 20240401233141.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240331s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2478/acph-2024-0002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1359.xml |
| 035 | |a (DE-627)NLM370439120 | ||
| 035 | |a (NLM)38554388 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zouhri, Aziz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chemical composition and potential antioxidant, anti-inflammatory, and analgesic efficacy of Cistus albidus L |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.04.2024 | ||
| 500 | |a Date Revised 01.04.2024 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 Aziz Zouhri et al., published by Sciendo. | ||
| 520 | |a This study aims to assess the chemical composition of the aqueous extract of Cistus albidus L. leaves, as well as the potential of aqueous and hydroethanol extracts of the leaves and seeds as analgesic, anti--inflammatory, and antioxidant agents. The contents of phenolics and inorganic constituents were determined in C. albidus seeds and leaves; antioxidant capacity was assessed by 3 complementary and diverse tests. The carrageenan-induced paw edema technique was used to investigate the anti-inflammatory effect in vivo, and albumin denaturation to evaluate the anti-inflammatory effect in vitro. The acetic acid-induced contortion test, the tail-flick test, and the plantar test were used to assess the analgesic effi cacy in vivo. Chemical analysis was performed by UPLC-MS/MS to quantify several phenolic compounds including catechin (1,627.6 mg kg-1), quercitrin (1,235.8 mg kg-1) and gallic acid (628. 2 mg kg-1). The ICP analysis revealed that potassium and calcium were the main inorganic components in the seeds and leaves of C. albidus. The hydroethanolic extract of the leaves showed the highest content of polyphenols/flavonoids, whereas the highest value of proantho cyanidins was detected in the aqueous extract of the seeds. All extracts showed potent antioxidant activity related to different phenolic compounds (quercetin, gallic acid, astragalin, catechin, and rutin). The aqueous extract of the leaves strongly inhibited paw edema (76.1 %) after 6 h of treatment and showed maximal inhibition of protein denaturation (191.0 µg mL-1 for 50 % inhibition) and analgesic activity in different nociceptive models. The presented data reveal that C. albidus extracts potentially show antioxidant, anti-inflammatory, and analgesic activities that could confirm the traditional use of this plant | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cistus albidus L. | |
| 650 | 4 | |a analgesic activity | |
| 650 | 4 | |a anti-inflammatory | |
| 650 | 4 | |a antioxidant activity | |
| 650 | 4 | |a polyphenols | |
| 650 | 7 | |a Antioxidants |2 NLM | |
| 650 | 7 | |a Catechin |2 NLM | |
| 650 | 7 | |a 8R1V1STN48 |2 NLM | |
| 650 | 7 | |a Plant Extracts |2 NLM | |
| 650 | 7 | |a Analgesics |2 NLM | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Phenols |2 NLM | |
| 650 | 7 | |a Gallic Acid |2 NLM | |
| 650 | 7 | |a 632XD903SP |2 NLM | |
| 700 | 1 | |a Bouddine, Toufik |e verfasserin |4 aut | |
| 700 | 1 | |a Menyiy, Naoual El |e verfasserin |4 aut | |
| 700 | 1 | |a El-Mernissi, Yahya |e verfasserin |4 aut | |
| 700 | 1 | |a Laaroussi, Hassan |e verfasserin |4 aut | |
| 700 | 1 | |a Chebaibi, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Amhamdi, Hassan |e verfasserin |4 aut | |
| 700 | 1 | |a Elharrak, Abdelhay |e verfasserin |4 aut | |
| 700 | 1 | |a Nafidi, Hiba-Allah |e verfasserin |4 aut | |
| 700 | 1 | |a Sitotaw, Baye |e verfasserin |4 aut | |
| 700 | 1 | |a Jardan, Yousef A Bin |e verfasserin |4 aut | |
| 700 | 1 | |a Bourhia, Mohammed |e verfasserin |4 aut | |
| 700 | 1 | |a Hajji, Lhoussain |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta pharmaceutica (Zagreb, Croatia) |d 1997 |g 74(2024), 1 vom: 01. März, Seite 81-99 |w (DE-627)NLM092561411 |x 1846-9558 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2024 |g number:1 |g day:01 |g month:03 |g pages:81-99 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2478/acph-2024-0002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 74 |j 2024 |e 1 |b 01 |c 03 |h 81-99 | ||